Open Accessibility Menu

Dallas Clinical Trials for Liver Disease

Explore New Options for Liver Disease Treatment

In clinical trials, patients participate in medical treatments that have not yet been approved for public use. These treatments have gone through rigorous safety tests before they enter the clinical trial stage, but their effectiveness still requires testing before it can be fully implemented as a standardized treatment.

Clinical trials are usually recommended for patients who have not had much success with regular treatments. By participating in a clinical trial, you will have an opportunity to explore new approaches to liver disease treatments not yet available to the public.

Are There Risks?

There are some risks to participating in a clinical trial, which is why you must give express consent before being allowed to participate. While the treatments offered have been tested for safety, there may be some uncertainty as to how potent the side effects are. There is also no guarantee that the treatment will be effective, but this is not usually a concern for patients who are not responding to standard treatments.

There are four phases to clinical trials:

  • Phase 1 – The earliest stage of experimentation. Only a small number of patients are allowed to participate in this stage to test the safety and side effects of the treatment.
  • Phase 2 – This phase is focused on the effectiveness of the treatment. More patients are invited to test the treatment so as to observe how the treatment works for various types of people.
  • Phase 3 – More people are allowed to participate in the trial to collect a wider range of data. The FDA will decide whether or not to approve the treatment at this stage.
  • Phase 4 – Some additional testing must continue even after the treatment has been approved by the FDA. At this stage, the goal is to assess the treatment’s long-term side effects.

Our staff will let you know if you are a candidate for clinical trials. This may be the right course for you if you find current treatments unsatisfactory and would like to contribute to the development of new medicine.